Rivastigmine and valsartan co-amorphous compound as well as preparation method, composition and application of rivastigmine and valsartan co-amorphous compound
The invention belongs to the technical field of medicines, and discloses a rivastigmine and valsartan co-amorphous compound, a preparation method, a pharmaceutical composition and application thereof. Specifically, the invention discloses a solid substance state of a co-amorphous compound of rivastigmine and valsartan. The invention relates to a preparation method of a rivastigmine and valsartan co-amorphous compound solid substance sample. The rivastigmine and valsartan co-amorphous compound is used as an active ingredient to be applied to preparation of drugs for preventing or treating cardiovascular diseases or neurodegenerative diseases or complications of the cardiovascular diseases or the neurodegenerative diseases. # imgabs0 #.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 14. Nov. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LYU YANG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-14, Last update posted on www.tib.eu: 2024-02-05, Last updated: 2024-02-09 |
|---|
| Patentnummer: |
CN117045646 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA019091257 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA019091257 | ||
| 003 | DE-627 | ||
| 005 | 20240209083826.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240202s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA019091257 | ||
| 035 | |a (EPA)CN117045646 | ||
| 035 | |a (EPA)88652343 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LYU YANG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rivastigmine and valsartan co-amorphous compound as well as preparation method, composition and application of rivastigmine and valsartan co-amorphous compound |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-14, Last update posted on www.tib.eu: 2024-02-05, Last updated: 2024-02-09 | ||
| 520 | |a The invention belongs to the technical field of medicines, and discloses a rivastigmine and valsartan co-amorphous compound, a preparation method, a pharmaceutical composition and application thereof. Specifically, the invention discloses a solid substance state of a co-amorphous compound of rivastigmine and valsartan. The invention relates to a preparation method of a rivastigmine and valsartan co-amorphous compound solid substance sample. The rivastigmine and valsartan co-amorphous compound is used as an active ingredient to be applied to preparation of drugs for preventing or treating cardiovascular diseases or neurodegenerative diseases or complications of the cardiovascular diseases or the neurodegenerative diseases. # imgabs0 # | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a DU GUANHUA |4 aut | |
| 700 | 0 | |a ZHANG LI |4 aut | |
| 700 | 0 | |a WANG SHOUBAO |4 aut | |
| 700 | 0 | |a YUAN PENGHUI |4 aut | |
| 700 | 0 | |a YU MINGCHAO |4 aut | |
| 700 | 0 | |a YIN SUYUE |4 aut | |
| 700 | 0 | |a WANG RUONAN |4 aut | |
| 700 | 0 | |a YAN LIUYAN |4 aut | |
| 700 | 0 | |a YANG SHIYING |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 14. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:14 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88652343/publication/CN117045646A1?q=CN117045646 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 14 |c 11 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 14 |c 11 | ||